7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
1/12
!"#" %&'(") %*+)&,&,"- ."/0"+1'12(
31 4 %15* !% 3"0" !% 6%6 %11/5(-"#1/
!% 72"-8('9
%11/5(-"#1/
!% 72*-":9
!"#$%#"& ()*+,*- ./,/) 012,*21314* 5 6*7*/+ 8/9/*:;3*
!"#$%#"< =/):/21.*+/:*2 & >/?)*/3.* =)/+,
!"#$%#"@ =/):/212*+A0*2 5 B)* C !A37/
!"#$%#"% !A01.1314* DE F GH( 5 "A9* IA37*+/ B+44*
!"#$%#" (A+A:;/+ F -A+4A:J/+4/+ 1J/0 & B)* C !A37/
!"#$%#"5#& KA2+*2 ./3/: -A+A:;/+ F
-A+4A:J/+4/+ 1J/0
& B)* C 8/9/*:;3*
!"#$%#"&&@ C?A2 ,/:-*+4 ./+ *+0A)/2,* 1J/0 & 6*7*/+ L+,0*/0M
!"#$%#"&&N ()*+,*- ./,/) A7/3;/,* 1J/0 & 8/9/*:;3* !A37/
!"#$%#"&&% C7/3;/,* ;+0;2 )A4*,0)/,* 1J/0 & !A37/ "A9* IA37*+/
!"#$%#"N =/):/214A+1:*2 O & L+,0*/0M !A37/
!"#$%#"P ()*+,*- ./,/) 0A)/-* /+0*:*2)1J/ O & 8/9/*:;3* B)* C
!"#$%#"&&P =/):/21314* /+0*:*2)1J/ O & "A9* IA37*+/ Q*/+01
!"#$%#"R =/):/21314* 1J/0 2/).*17/,2;3A) O 5 8/9/*:;3* =)/+,
!"#$%#"& SJ/0 TA)J/3 O & 6*7*/+ (;)9/+0M/,0;0*
!"#$%#"&&< >A;)1?/):/21314* O & 8/9/*:;3* 8/9/*:;3*
!"#$%#"&&R C+.12)*+1?/):/21314* O & L+,0*/0M "A9* IA37*+/
!"#$%#"&&$ EA:10A)/-A;0*2 ./+ J*10A)/-A;0*2 O & !A37/ 6*7*/+
; :('()"- 5"'"0 +*+)&,&,"- ."/0"+1'12(
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
2/12
6*
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
3/12
!"#" %&'(") N L/(-,(: 5","/ #1+,(+1'12(
%15* !% N !" #$%#"&
6%6 N A
%11/5(-"#1/ !% N 6*0*,#*/ 2"-8(' N !*'O"
6*0*,#*/ 2*-": N P"Q"(0&'(
31 >1:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& (A+4/+0/) ./+ -)*+,*- 012,*21314* 5 =)/+, =)/+,
5 !;0/4A+A,*, ./+ -A:A)*2,//+
:;0/4A+A,*,
5 !A37/ B)* C
@ KA)/014A+A,*, ./+ -A:A)*2,//+
0A)/014A+A,*,
5 !A37/ B)* C
P E/),*+14A+A,*, ./+ -A:A)*2,//+
2/),*+14A+A,*,
5 !A37/ B)* C
< K12,*,*0/, J/T/+ 2*:*/ /2*J/0 2A)U/ ./+
3*+42;+4/+
P B)* C B)* C
R ()*+,*- ./,/) .*/4+1,*, ./+
-A+4/+44;3/+4/+ 2A)/Z;+/+ /2;0 -/./
:/+;,*/
5 =)/+, =)/+,
$ (A:A)*2,//+ (B ;+0;2 -A:A)*2,//+
012,*,*0/,
5 6*7*/+ 8/9/*:;3*
% K12,*21314* /+/3*0*2 5 B)* C B)* C
N K12,*,*0/, ,-A,*?*2 1)4/+ 5 6*7*/+ 8/9/*:;3* I0)A, 12,*./0*? ./+ /+0*12,*./+ 5 =)/+, =)/+,
&& (A:A)*2,//+ 012,*,*0/, /2;0 @ =)/+, =)/+,
&5 (A:A)*2,//+ 012,*,*0/, 2)1+*2 @ =)/+, =)/+,
&@ DU*/+ L 5 !A37/ 8/9/*:;3*
&P DU*/+ LL 5 !A37/ 8/9/*:;3*
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
4/12
!"#" %&'(") N ."/0"+1+(-*#(+
E1.A !E [ !" #$%#"@
6%6 N A
%11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N D/( =
,*0*,#*/ 2*-": N !*'O"
31 >1:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& K)/+,-1) 1J/0 3*+0/, :A:J)/+ & B)* C !A37/
5 BJ,1)-,* 5 B+44* "A9* IA37*+/
@ \*1/7/*3/J*3*0/, ./+ J*1A2*7/3A+,* 5 B+44* "A9* IA37*+/
P "*,0)*J;,* ./+ *2/0/+ -)10A*+ 5 B)* C !A37/
< !A0/J13*,:A 1J/0 ./+ 23*)A+, TA-/) P B)* C !A37/
R C2,2)A,* ./+ 23*)A+, 4*+U/3 @ 6*7*/+ 8/9/*:;3*
$ (A+4/);T -A+M/2*0 0A)T/./-
?/):/212*+A0*2 1J/0
5 B+44* 8/9/*:;3*
% (A+4/);T ;,*/ 0A)T/./- ?/):/212*+A0*2
1J/0
5 6*7*/+ 8/9/*:;3*
N (A+MA,;/*/+ .1,*, -/./ 4/4/3 4*+U/3 5 6*7*/+ 8/9/*:;3*
E*+A0*2/ -1-;3/,* 5 B)* C !A37/
&& =/):/212*+A0*2 23*+*2 5 Q*/+01 Q*/+01
&5 ]/0*T/+ ,1/3 ?/):/212*+A0*2 23*+*2 P Q*/+01 Q*/+01
&@ DU*/+ & 5 B)* C !A37/
&P DU*/+ 5 5 B)* C !A37/
!"#" %&'(") N ."/0"+15(-"0(+
%15* !% N !" #$%#":(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& QA,A-01) P =)/+, =)/+,
5 ()*+,*- /41+*,X/+0/41+*, 5 =)/+, =)/+,
@ ^;J;+4/+ .1,*,XA?A2 5 =)/+, =)/+,
P !A2/+*,:A 0)/+,.;2,* ,*+M/3 @ >/?)*/3.* >/?)*/3.*
< ^;J;+4/+ ,0);20;)X/20*7*0/, @ !A37/ !A37/
R DU*/+ 5 >/?)*/3.* =)/+,
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
5/12
!"#" %&'(") N L/(-,(: 5","/ #*/":( "-#(0(+/11:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& ()*+,*- ;:;: 0A)/-* /+0*:*2)1J/ @ Q*/+01 Q*/+01
5 (E_(" F !(H
V!"#$%# '()*)%#+,% -,%-)%#($#+,%W
@ Q*/+01 Q*/+01
@ !A2/+*,:A )A,*,0A+,* 5 Q*/+01 >/?)*/3.*
P .%+!$/ !,0)/ ,1 +%1)-#+,% 1,( 2#"03
,1 $%#+!+-(,4+$/ '5$(!$-,03%$!+-2
5 Q*/+01 >/?)*/3.*
< 6+,$22$3-10A+,* /+0*:*2)1J/ 5 8/9/*:;3* B)* C
R !1.A3 +% *+#(,;+0;2 )A,*,0A+,*
/+0*:*2)1J/
5 8/9/*:;3* B)* C
$ DU*/+ 5 8/9/*:;3* B)* C
!"#" %&'(") N ."/0"+1'12( "-#(0(+/11:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& =/):/21314* /+0*J*10*2/ P L+,0*/0M Q*/+01
5 =/):/21314* /+0*7*);, 5 "A9* IA37*+/ Q*/+01
@ =/):/21314* /+0*U/:;) 5 "A9* IA37*+/ B)* C
P =/):/21314* /+0*-/)/,*0
V:/3/)*/` TA3:*+0T` -)101a1/`
?*3/)*/W
P L+,0*/0M B)* C
< =/):/21314* /+0*:*21J/20A)* 5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*
R DU*/+ 5 "A9* IA37*+/ Q*/+01
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
6/12
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
7/12
!"#" %&'(") N L/(-,(: C","/ =O"'&",( 11:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& 7,8 #, 5$%0/) ()9+2#($#+,% 0,22+)( 5 !A37/ "A9* IA37*+/
5 C7/3;/,* 1J/0 U/.* J/); @ !A37/ "A9* IA37*+/
@ C7/3;/,* 1J/0 Z1-M 5 !A37/ "A9* IA37*+/
P C7/3;/,* J*1,*:*3/) @ Q*/+01 Q*/+01
< C7/3;/,* 1J/0 0)/.*,*1+/3 5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*
R C7/3;/,* ,;-3A:A+ F -/+4/+
?;+4,*1+/3
5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*
$ DU*/+ 5 !A37/ "A9* IA37*+/
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
8/12
!"#" %&'(") N !*#151'12( &8( +'(-(+ 5"- TUL
%15* !% N !"#$%#"%
6%6 N @%11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N C*Q( 6*'O(-"
,*0*,#*/ 2*-": N D-22(
31 >1:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& (A+4/+0/) ./+ .*,/*+ ;U* 23*+*2 @ Q*/+01 Q*/+01
5 \A,/) ,/:-A3 ./+ 3/0*T/+ @ B+44* B+44*
@ Q/+.1:*,/,* ./+ 3/0*T/+ & L+,0*/0M L+,0*/0M
@ E1+0)13 ./+ 2A0A),/:/)/+ & "A9* IA37*+/ "A9* IA37*+/
P "/0/ ./+ :/+/UA:A+ ./3/: DE 5 !A37/ L+,0*/0M
< B+/3*,*, ./0/ ./+ *+0A)-)A0/,*
T/,*3 DE
@ !A37/ !A37/
R (A+M;,;+/+ -)101Z13 DE F
3/0*T/+
@ !A37/ Q*/+01
$ \*/, ./+ Z1+?1;+.*+4 ./3/: DE 5 (;)9/+0M/,0;0* B+44*
% QA4;3/,* DE .* L+.1+A,*/ 5 (;)9/+0M/,0;0* >/?)*/3.*
N "A23/)/,* ^A3,*+2* & >/?)*/3.* B+44*
()*+,*- LH^XGH( ./+ E1:*,* C0*2 5 >/?)*/3.* B+44*
(A+A3*0* 5 "A9* IA37*+/ B+44*&& L+?1):/,* ;+0;2 Z/31+ ,;JMA2 ./+
3/0*T/+
@ (;)9/+0M/,0;0* Q*/+01
&< DU*/+ & 5 "A9* IA37*+/ B+44*
&R DU*/+ 5 5 "A9* IA37*+/ B+44*
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
9/12
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
10/12
!"#" %&'(") N ."/0"+12*-10(+ ;
%15* !% N !"#$%#"N
6%6 N @%11/5(-"#1/ !% N ,*0*,#*/ 2"-8('N G-,#("#W
,*0*,#*/ 2*-":N !*'O"
31 >1:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& (A+4/+0/) ?/):/214A+1:*2 5 =)/+, =)/+,
5 =/):/214A+1:*2 -/./ )A,A-01) 5 L+,0*/0M !A37/
@ =/):/214A+1:*2 -/./ A+a*:
:A0/J13*,:A
5 L+,0*/0M Q*/+01
P =/):/214A+1:*2 -/./ 0)/+,-1)0A)
:A:J)/+A
5 L+,0*/0M !A37/
< (A)/+ ?/):/214A+1:*2 -/./
-A+A:;/+ ./+ -A+4A:J/+4/+ 1J/0
5 =)/+, =)/+,
R B-3*2/,* ?/):/214A+1:*2 ./3/:
?/):/210A)/-*
5 L+,0*/0M Q*/+01
$ KA2+*2 3/J1)/01)*;: ./3/:
?/):/214A+1:*2
5 L+,0*/0M !A37/
% DU*/+ 5 L+,0*/0M !A37/
!"#" %&'(") N L*-*0&"- 5"- L*-2*0
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
11/12
7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015
12/12
!"#" %&'(") N =-51+/(-1S"/0"+1'12( ;
%15* !% N !"#$%#"&&R
6%6 N @
%11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N G-,#("#W,*0*,#*/ 2*-": N C*Q( 6*'O(-"
31 >1:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& ^1):1+ 2A3/:*+ ./+
21+0)/,A-,* T1):1+/3
P "A9* IA37*+/ "A9* IA37*+/
5 L+,;3*+ ./+ /+0*.*/JA0*2 1)/3 P Q*/+01 Q*/+01
@ K*)1*.` /+0*0*)1*. 5 6*7*/+ 6*7*/+
P SJ/0 M/+4 :A:-A+4/);T*
:A0/J13*,:A 0;3/+4
5 6*7*/+ 6*7*/+
< E1)0*21,0A)1*. 5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*
R DU*/+ 5 "A9* IA37*+/ 6*7*/+
!"#" %&'(") N ."/0"+1'12( %*01#*/":*(+ 5"- K(1#*/":*(+ ;
%15* !% N !"#$%#"&&$
6%6 N @
%11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N !*'O"
,*0*,#*/ 2*-": N V(O("-
31 >1:(+ R&0'")
R"0
L*-2"8"/
7,*0 2"-8('9
L*-2"8"/
7,*0 2*-":9
& E/+2A) ./+ :1./3*0/, 0A)/-* -/./
2/+2A)
5 >/?)*/3.* >/?)*/3.*
5 B+0*2/+2A) 21+7A+,*1+/3 @ >/?)*/3.* >/?)*/3.*@ \*10A)/-A;0*2 ./+ 0A)/-* 0/)4A0 @ !A37/ 6*7*/+
P !A2/+*,:A )A,*,0A+,* ,A3 2/+2A)
0A)T/./- 2A:10A)/-*
5 !A37/ 6*7*/+
< C?A2 ,/:-*+4 ./+ 012,*,*0/, /+0*2/+2A) 5 8/9/*:;3* 8/9/*:;3*
R (A+4A:J/+4/+ 1J/0 /+0*2/+2A) J/); 5 !A37/ 6*7*/+
$ DU*/+ 5 !A37/ 6*7*/+